Home » Epigenomics Signs Agreement With NextPharma for Epi proColon
Epigenomics Signs Agreement With NextPharma for Epi proColon
Epigenomics AG, a Germany-based cancer molecular diagnostics company, and NextPharma Technologies have signed a global manufacturing agreement for Epigenomics’ Epi proColon product.
TradingMarkets
TradingMarkets
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May